| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| YS Biopharma (LSB) | China | $0.084B | 0.00 |
| FLJ Group (XHG) | China | $0.003B | 0.00 |
| Inhibrx (INBX.) | United States | $0.000B | 0.00 |